Clinical trial
A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects
NCT00397566 · Bristol-Myers Squibb, Industry · Withdrawn
Key facts
| NCT number | NCT00397566 |
|---|---|
| Title | A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects |
| Official title | Randomized, Placebo-Controlled, Ascending Multiple Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-707035 in HIV-1 Infected Subjects |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | HIV Integrase Inhibitor (BMS-707035) |
| Enrollment | 0 |
| Start date | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Nov 9, 2006 |
| Last update posted | Apr 27, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: